X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-25 | CYRX | Stefanovich Robert | CFO | S - Sale | $17.54 | -1,079 | 128,333 | -1% | -$18,928 | ||||||
2024-03-25 | CYRX | Shelton Jerrell | CEO | S - Sale | $17.54 | -2,631 | 692,182 | 0% | -$46,154 | ||||||
2024-03-25 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale | $17.54 | -1,367 | 77,444 | -2% | -$23,980 | ||||||
DM | 2024-03-11 | CYRX | Stefanovich Robert | CFO | S - Sale+OE | $15.91 | -2,154 | 129,412 | -2% | -$34,271 | |||||
DM | 2024-03-11 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale+OE | $15.91 | -2,730 | 78,811 | -3% | -$43,435 | |||||
D | 2024-03-15 | CYRX | Mandalam Ramkumar | Dir | S - Sale+OE | $14.68 | -3,217 | 43,187 | -7% | -$47,226 | |||||
DM | 2024-03-11 | CYRX | Shelton Jerrell | Pres, CEO | S - Sale+OE | $15.37 | -60,762 | 694,813 | -8% | -$933,764 | |||||
2023-12-14 | CYRX | Hariri Robert J | Dir | S - Sale | $16.89 | -800 | 12,716 | -6% | -$13,512 | ||||||
2023-12-11 | CYRX | Hariri Robert J | Dir | S - Sale | $15.50 | -1,000 | 13,516 | -7% | -$15,500 | ||||||
2023-09-06 | CYRX | Hariri Robert J | Dir | S - Sale | $13.60 | -1,500 | 14,516 | -9% | -$20,400 | ||||||
D | 2023-09-01 | CYRX | Shelton Jerrell | See Remarks | S - Sale+OE | $14.27 | -26,875 | 632,424 | -4% | -$383,407 | |||||
2023-05-11 | CYRX | Berman Richard J | Dir | S - Sale | $21.51 | -7,203 | 100,000 | -7% | -$154,906 | ||||||
D | 2023-05-10 | CYRX | Shelton Jerrell | Pres, CEO | S - Sale+OE | $21.63 | -141,159 | 605,299 | -19% | -$3,053,509 | |||||
D | 2023-05-10 | CYRX | Stefanovich Robert | CFO | S - Sale+OE | $21.94 | -19,918 | 107,150 | -16% | -$437,023 | |||||
2023-03-15 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale | $20.79 | -1,362 | 61,670 | -2% | -$28,316 | ||||||
2023-03-15 | CYRX | Shelton Jerrell | CEO | S - Sale | $20.79 | -2,599 | 432,989 | -1% | -$54,033 | ||||||
2023-03-15 | CYRX | Stefanovich Robert | CFO | S - Sale | $20.79 | -1,069 | 96,695 | -1% | -$22,225 | ||||||
D | 2023-03-13 | CYRX | Stefanovich Robert | CFO | S - Sale+OE | $20.14 | -1,159 | 97,764 | -1% | -$23,342 | |||||
D | 2023-03-13 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale+OE | $20.14 | -1,476 | 63,032 | -2% | -$29,727 | |||||
D | 2023-03-13 | CYRX | Shelton Jerrell | CEO | S - Sale+OE | $20.14 | -3,798 | 435,588 | -1% | -$76,492 | |||||
2022-12-01 | CYRX | Berman Richard J | Dir | S - Sale | $19.63 | -7,250 | 0 | -100% | -$142,316 | ||||||
2022-08-16 | CYRX | Berman Richard J | Dir | S - Sale | $43.05 | -2,708 | 107,203 | -2% | -$116,588 | ||||||
2022-08-11 | CYRX | Hariri Robert J | Dir | S - Sale | $43.29 | -2,000 | 7,911 | -20% | -$86,581 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |